Status:
RECRUITING
Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM
Lead Sponsor:
Universiti Putra Malaysia
Conditions:
Type 2 Diabetes Mellitus
Obesity
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Globally, chronic noncommunicable diseases rank as the leading cause of morbidity and mortality. Diabetes is reaching high epidemic proportions across the globe. The prevalence of diabetes is increasi...
Detailed Description
A randomized controlled trial study will be conducted among adults with Type 2 diabetes who referred to the diabetes center to optimise dietary intervention for diabetes control in King Fahad Medical ...
Eligibility Criteria
Inclusion
- Aged 18 years old and above.
- Diagnosis of Type 2 diabetes.
- Receiving and monitoring diabetes care from diabetes center.
- With stable HbA1c less than 10% (no episode of hypoglycaemia, no hospitalisation, no change in type or dosage of medication use for at least 6 months).
Exclusion
- Pregnant or lactating women.
- Diagnosis of cardiac failure or/and severe renal disease, with physical or mental disability, neurological or cognitive impairment.
- Participant with severely impaired vision, hearing, or speech.
- Participants who have known allergy to dates products.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06590519
Start Date
July 1 2024
End Date
December 30 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Zuriati Ibrahim
Serdang, Selangor, Malaysia, 43400